Skip to main content
TipRanks
Go Ultimate75% OFF

ADARx Pharmaceuticals (ADRX) Ownership - Who Owns ADARx Pharmaceuticals?

9 Followers

ADARx Pharmaceuticals (ADRX) Ownership Overview

  • 29.02% Insiders
  • 57.64% Other Institutional Investors
  • 0.05% ETFs
  • 13.29% Public Companies and Individual Investors

The ownership structure of ADARx Pharmaceuticals (ADRX) stock is a mix of institutional, retail, and individual investors. Approximately 57.69% of the company’s stock is owned by Institutional Investors, 29.02% is owned by Insiders, and 13.29% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Sep 29, 2026Erez Chimovits$1,045,772
Sep 29, 2026Orbimed Advisors Llc$16,150,000
Sep 29, 2026Carl Gordon$16,150,000
Sep 28, 2026Sr One Capital Management, Llc$27,200,000

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Sep 30, 2026 $46,582,033
Sep 30, 2026Woodline Partners Lp$29,181,751
Sep 30, 2026Perceptive Advisors Llc$5,982,000
Sep 30, 2026Blackstone Inc.$8,408,718

Top Shareholders

ADRX top shareholders
Holder# of SharesType% HoldingValue
Lav Biosciences Fund V, L.p.11,858,655Insider10.66%166,021,170
Sr One Capital Management, Llc9,936,661Insider8.94%139,113,254
Erez Chimovits9,292,025Insider8.36%130,088,350
BlackRock, Inc.2,336,110Institution2.10%32,705,540
Michael Rockefeller1,463,478Institution1.32%20,488,692
Orbimed Advisors Llc588,235Insider0.53%8,235,290
Carl Gordon588,235Insider0.53%8,235,290
Stephen A. Schwarzman421,701Institution0.38%5,903,814
Joseph Edelman300,000Institution0.27%4,200,000
Vanguard46,894Institution0.04%656,516

Top ETF Holders

ADRX top ETF holders
Holder# of SharesType% HoldingValue
Vanguard Total Stock Market ETF, VTI ETF30,645Institution0.03%520,965
Vanguard Extended Market ETF, VXF ETF11,701Institution0.01%198,917
T. Rowe Price Health Care ETF, TMED ETF5,802Institution<0.01%78,733
Vanguard Russell 2000 ETF, VTWO ETF4,004Institution<0.01%68,068
T. Rowe Price Biotech ETF, TDNA ETF1,359Institution<0.01%18,442
T. Rowe Price Small Cap ETF, TSEE ETF453Institution<0.01%6,147
Vanguard Russell 2000 Growth ETF, VTWG ETF402Institution<0.01%6,834
Fidelity Global Equity+ Balanced Fund Trust Units, TSE:FGEB ETF274Institution<0.01%7,785
Vanguard Russell 2000 Value ETF, VTWV ETF142Institution<0.01%2,414

FAQ

Who Owns ADARx Pharmaceuticals (ADRX)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 57.69% of the company's stock is held by institutional investors, 29.02% is held by insiders, and 13.29% is held by public companies and individual investors.
What percentage of ADARx Pharmaceuticals (ADRX) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 57.69% of ADARx Pharmaceuticals (ADRX) stock is held by institutional investors: 0.05% by ETFs and 57.64% by other institutional investors.
What percentage of ADARx Pharmaceuticals (ADRX) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 13.29% of ADARx Pharmaceuticals (ADRX) stock is held by public companies and individual investors.
Who owns the most shares of ADARx Pharmaceuticals (ADRX)?
LAV Biosciences Fund V, L.P. owns the most shares of ADARx Pharmaceuticals (ADRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.